Search - tctmd.com

Displaying 1 - 20 of 216

Sort: Relevancy | Date

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

News Conference News ACC 2026

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

April 02, 2026

Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF

News Conference News ACC 2026

Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF

April 02, 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

News Conference News ACC 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

April 02, 2026

Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b

News Conference News ACC 2026

Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b

Yael L. Maxwell

April 01, 2026

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’

News Conference News ACC 2026

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’

March 31, 2026

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

News Conference News ACC 2026

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

March 30, 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

March 30, 2026

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

News Conference News ACC 2026

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

Michael O'Riordan

March 29, 2026

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

News Conference News ACC 2026

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

March 29, 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

News Conference News ACC 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

Yael L. Maxwell

March 28, 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

March 28, 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

News Conference News ACC 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

March 28, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

April 10, 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

News Conference News ACC 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

Yael L. Maxwell

April 07, 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

News Conference News ACC 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

April 07, 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

April 03, 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

March 31, 2025

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

News Conference News ACC 2025

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

March 31, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.